Search Results - "Tschida, S J"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Atracurium resistance in a critically Ill patient by Tschida, S J, Hoey, L L, Nahum, A, Vance-Bryan, K

    Published in Pharmacotherapy (01-07-1995)
    “…A previously healthy 25-year-old man with metastatic testicular teratocarcinoma became resistant to atracurium-induced neuromuscular blockade as evidenced by…”
    Get more information
    Journal Article
  2. 2

    The impact of practice guidelines on prescribing patterns of nondepolarizing neuromuscular blocking agents by Tschida, S J, Hoey, L L, Vance-Bryan, K

    Published in Pharmacotherapy (01-09-1996)
    “…Guidelines for selecting nondepolarizing neuromuscular blocking agents (NNMBAs) were developed and implemented by an interdisciplinary team for use in our…”
    Get more information
    Journal Article
  3. 3

    A retrospective study of sodium nitroprusside use and assessment of the potential risk of cyanide poisoning by Johanning, R J, Zaske, D E, Tschida, S J, Johnson, S V, Hoey, L L, Vance-Bryan, K

    Published in Pharmacotherapy (01-11-1995)
    “…Sodium nitroprusside (SNP) is an effective vasodilator but is potentially dangerous due to its cyanide content. Infusion rates above 2 micrograms/kg/minute may…”
    Get more information
    Journal Article
  4. 4

    Resistance to nondepolarizing neuromuscular blocking agents by Tschida, S J, Graupe, K J, Hoey, L L, Vance-Bryan, K

    Published in Pharmacotherapy (01-05-1996)
    “…Several case reports of resistance to short-term administration of nondepolarizing neuromuscular blocking agents (NNMBAs) have been reported in research and…”
    Get more information
    Journal Article
  5. 5

    Anti-infective agents and hepatic disease by Tschida, S J, Vance-Bryan, K, Zaske, D E

    “…Numerous factors such as changes in plasma protein binding, tissue binding, hepatic blood flow, hepatic metabolism, and distribution may occur in hepatic…”
    Get more information
    Journal Article
  6. 6
  7. 7
  8. 8

    Inconsistency with train-of-four monitoring in a critically ill paralyzed patient by Tschida, S J, Hoey, L L, Vance-Bryan, K

    Published in Pharmacotherapy (01-07-1995)
    “…Problems occurred with train-of-four (TOF) monitoring during prolonged therapy with nondepolarizing neuromuscular blocking agents (NNMBAs). A previously…”
    Get more information
    Journal Article
  9. 9

    Train-of-four: to use or not to use by Tschida, S J, Hoey, L L, Mather, D, Vance-Bryan, K

    Published in Pharmacotherapy (01-07-1995)
    “…A pattern of nerve stimulation called train-of-four (TOF) is frequently used to monitor therapy with nondepolarizing neuromuscular blocking agents in patients…”
    Get more information
    Journal Article
  10. 10

    Wide variation in single, daily-dose aminoglycoside pharmacokinetics in patients with burn injuries by Hoey, L L, Tschida, S J, Rotschafer, J C, Guay, D R, Vance-Bryan, K

    Published in Journal of burn care & rehabilitation (01-03-1997)
    “…Five to seven mg/kg single, daily-dose aminoglycoside regimens have been recently advocated as effective alternatives to traditional aminoglycoside regimens…”
    Get more information
    Journal Article
  11. 11

    QTc-interval prolongation associated with slow intravenous erythromycin lactobionate infusions in critically ill patients: a prospective evaluation and review of the literature by Tschida, S J, Guay, D R, Straka, R J, Hoey, L L, Johanning, R, Vance-Bryan, K

    Published in Pharmacotherapy (01-07-1996)
    “…Intravenous erythromycin has recently been associated with significant QTc interval prolongation, torsades de pointes, and sudden cardiac death. The prolonged…”
    Get more information
    Journal Article